COVID-19 caused by 2019 novel coronavirus (2019-nCoV2) also known as SARS-CoV-2 has manifested globally since January 2020. COVID-19 was declared as a pandemic by the WHO and has become a serious global health concern. Real-time PCR based and antibody-based assays are being used for the clinical detection of the virus in body fluids and nasopharyngeal swabs. Antibody variability linked to viral mutations is a big concern. Hence, it is of interest to use data patterns from mass spectrometry-based platforms for the identification of SARS-CoV-2. This dataset can be used to perform targeted mass-spectrometric analysis of SARS-CoV-2 peptides. This work can be extrapolated for the detection of SARS-CoV-2 viral peptides in complex biological fluids for early diagnosis of COVID-19.
【저자키워드】 COVID-19, SARS-CoV-2, targeted proteomics, tryptic peptides, Skyline, 【초록키워드】 pandemic, peptide, SARS-CoV-2 peptides, virus, early diagnosis, 2019 novel coronavirus, Health, PCR, nasopharyngeal swabs, dataset, platform, Analysis, body fluid, complex, Variability, viral mutation, biological fluid, SARS-CoV-2 viral, caused, can be used, the WHO, manifested, 【제목키워드】 peptide, Diagnosis, proteome, the SARS-CoV-2,